Zhang W et al. oHSV2 Can Target Murine Colon Carcinoma by Altering the Immune Status of the Tumor Microenvironment and Inducing Antitumor Immunity., , Mol Ther Oncolytics, Mar 16, 2020 ➔

Asleh K et al. Predictive biomarkers for adjuvant capecitabine benefit in early stage triple negative breast cancer in the FinXX clinical trial., , Clin Cancer Res, Jan 31, 2020 ➔

Jackson JL et al. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers., , Mol Neurodegener, Jan 31, 2020 ➔

Sharma M et al. Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy., , Nat Commun, Jan 31, 2020 ➔

Su J et al. Prognostic Molecular Classification of Appendiceal Mucinous Neoplasms Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy., , Ann Surg Oncol, Jan 24, 2020 ➔

Canel M et al. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity., , eLife, Jan 21, 2020 ➔

Wagener-Ryczek S et al. Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma., , Cancer Immunol Immunother, Jan 20, 2020 ➔

Figueiredo CR et al. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development., , J Pathol, Jan 20, 2020 ➔

Cabrita R et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma., , Nature, Jan 15, 2020 ➔

Helmink BA et al. B cells and tertiary lymphoid structures promote immunotherapy response., , Nature, Jan 15, 2020 ➔

Jiang J et al. Tumour-Infiltrating Immune Cell-Based Subtyping and Signature Gene Analysis in Breast Cancer Based on Gene Expression Profiles., , J Cancer, Jan 14, 2020 ➔

Scortegagna M et al. Siah2 control of T-regulatory cells limits anti-tumor immunity., , Nat Commun, Jan 07, 2020 ➔

Alves R et al. Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-alpha., , J Transl Med, Jan 03, 2020 ➔

Cesano A et al., Status of Immune Oncology: Challenges and Opportunities., , Methods Mol Biol, Jan 01, 2020 ➔

Das K et al., Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue., , Methods Mol Biol, Jan 01, 2020 ➔